View in EDS PDF Full Text

Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

Saved in:
Bibliographic Details
Title: Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Authors: Avallone, Gianluca1,2 (AUTHOR) gianluca.avallone2@gmail.com, Margiotta, Flavia Manzo3,4 (AUTHOR), Bombelli, Andrea1,2 (AUTHOR), Gargiulo, Luigi5,6 (AUTHOR), Foti, Caterina7 (AUTHOR), Trave, Ilaria8 (AUTHOR), Rossi, Mariateresa9 (AUTHOR), Magnaterra, Elisabetta10,11 (AUTHOR), Pigliacelli, Flavia12 (AUTHOR), Malagoli, Piergiorgio13 (AUTHOR), Giacalone, Serena14 (AUTHOR), Portarapillo, Antonio15 (AUTHOR), Patruno, Cataldo16 (AUTHOR), Schettini, Natale17 (AUTHOR), Bonzano, Laura18 (AUTHOR), Pezzolo, Elena19 (AUTHOR), Chello, Camilla20 (AUTHOR), Gori, Niccolò21,22 (AUTHOR), Brunasso, Giovanna23 (AUTHOR), Veronese, Federica24 (AUTHOR)
Source: Dermatology & Therapy. Jul2026, p1-7. 7p.
Database: Academic Search Ultimate
Description
ISSN:21938210
DOI:10.1007/s13555-026-01863-2